OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Processing Equipment Trends
Data analytics, modular equipment, digital tools, and risk-based validation improve speed, flexibility, and quality.
Opportunities and developments in particle engineering are providing developers with the tools to advance drug candidates successfully.
Advancements in soft capsule technology can enable the development of soft capsule formulations.
Examining new approaches, novel technologies, and the structural evolution of the raw materials market.
Replacing a step in sample preparation with an automated approach improves both method precision and productivity.
Advancing OSD: Continuous Production Considerations and Dose-Level Authentication
November 15, 2022
A look back at challenge and innovation highlights in 2022 for oral solid dosage forms, this podcast episode will review industry experts’ takes on factors driving the evolution of OSD forms as well as innovations in APIs, technology, and methodology.
November 14, 2022
The new facility will allow ReiThera to consolidate its competitive position as a leading CDMO specialized in viral vector production.
Avantor is continuing its investment to support the biopharma market with the opening of its new distribution center in Dublin, Ireland.
Salipro Biotech has entered into a collaboration and license agreement with Sanofi to advance discovery programs.
Address needs for integrated, automated systems and service.
November 11, 2022
The new Massachusetts facility will strengthen Cytiva’s cell culture services.
November 10, 2022
The results of the mid-term election may reduce Congress’ ability to pass FDA-related legislation during its lame duck session.
November 09, 2022
The UK MHRA has expanded the use of Cosentyx for use in pediatric arthritic conditions.
The latest guidance from FDA discusses recommendations on demonstrating sameness between the active ingredient in a proposed generic drug product and its reference listed drug.
November 08, 2022
The collaboration will see Shimadzu and UMG develop new clinical laboratory methods using LC-MS for TDM analysis.